Vol 52, No 6 (2021)
Editorial
Published online: 2021-12-23

open access

Page views 5729
Article views/downloads 328
Get Citation

Connect on Social Media

Connect on Social Media

Therapeutic drug monitoring: a key point in optimal treatment of invasive fungal disease

Jan Styczyński1
Acta Haematol Pol 2021;52(6):526-527.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Lehrnbecher T, Averbuch D, Castagnola E, et al. 8th European Conference on Infections in Leukaemia, 8th European Conference on Infections in Leukaemia. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021; 22(6): e254–e269.
  2. Gil L, Kałwak K, Piekarska A, et al. Antifungal management in adults and children with hematological malignancies or undergoing hematopoietic cell transplantation: recommendations of Polish Society of Hematology and Blood Transfusion, Polish Society of Pediatric Oncology and Hematology, and Polish Adult Leukemia Study Group, 2020. Acta Haematol Pol. 2020; 51(2): 60–72.
  3. Styczyński J, Czyżewski K, Ussowicz M, et al. Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers. Acta Haematol Pol. 2020; 51(3): 183–186.
  4. Styczyński J, Czyżewski K, Ussowicz M, et al. Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers. Acta Haematol Pol. 2020; 51(3): 183–186.
  5. Styczyński J, Piekarska A, Zaucha-Prażmo A, et al. Antimicrobial prophylaxis in adults and children undergoing hematopoietic cell transplantation: 2021 Polish recommendations. Acta Haematol Pol. 2021; 52(6): XXX–XXX.
  6. Liszka K, Resztak M, Zalewska P, et al. Therapeutic drug monitoring of posaconazole for effective prophylaxis of invasive fungal infections in pediatric patients. A pilot study. Acta Haematol Pol. 2021; 52(6): XXX–XXX.
  7. Luong ML, Al-Dabbagh M, Groll AH, et al. Utility of voriconazole therapeutic drug monitoring: a meta-analysis. J Antimicrob Chemother. 2016; 71(7): 1786–1799.
  8. Styczyński J. Infectious complications in children and adults with hematological malignancies. Acta Haematol Pol. 2019; 50(3): 167–173.
  9. Styczyński J, Czyżewski K, Frączkiewicz J, et al. Clinical spectrum and outcome of invasive mucormycosis in children and adults: Polish experience of the decade 2010–2019. Acta Haematol Pol. 2020; 51(3): 157–163.
  10. Giebel S, Basak G, Bieniaszewska M, et al. Current status and progress of Polish hemato-oncology. Acta Haematol Pol. 2021; 52(1): 4–17.